Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
June 30 2023 - 11:16AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES
EXCHANGE ACT OF 1934
For
the month of June 2023
Commission
File Number 001-40517
BON
NATURAL LIFE LIMITED
(Translation
of registrant’s name into English)
25F,
Rongcheng Yungu, Keji 3rd Road
Xi’an
Hi-Tech Zone, Xi’an, China
People’s
Republic of China
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form
40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report
to security holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that
the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on
which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to
be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the
subject of a Form 6-K submission or other Commission filing on EDGAR.
On
June 26, 2023, Lawrence W. Leighton resigned as a member of our board of directors. On June 28, 2023, Jeffrey J. Guzy also resigned as
a member of our board of directors. We are in the process of identifying and retaining new independent directors to serve on our board,
and we intend to have a majority independent board reimplemented within the cure period provided by Nasdaq Rule 5605(b)(1)(A). In addition,
we intend to reconstitute the independent audit committee and independent compensation committee of the board within the cure periods
provided by Nasdaq Rules 5605(c)(4)(B) and 5605(d)(4), respectively.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Date: June 30, 2023 |
Bon Natural Life Limited |
|
|
|
|
By: |
/s/ Yongwei
Hu |
|
|
Yongwei Hu |
|
|
Chairman and Chief Executive Officer |
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Jul 2024 to Aug 2024
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Aug 2023 to Aug 2024